Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about INFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Neuroinflammation is a key driver of neurodegenerative disease progression. It involves activation of microglia and astrocytes, release of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), complement cascade activation, and blood-brain barrier disruption. While acute inflammation is neuroprotective, chronic neuroinflammation exacerbates neuronal damage. Key pathways include NF-kB, JAK-STAT, NLRP3 inflammasome, and TLR signaling.
No AI portrait yet
| Gene Symbol | INFLAMMATION |
| Mitochondrial protection | In primary dopaminergic neurons, O-GlcNAcylated alpha-synuclein showed reduced mitochondrial localization and less mitochondrial fragmentation on TOM20 immunostaining |
| In vivo PD model | OGA inhibition in MPTP-treated mice reduced dopaminergic neuronal loss in the substantia nigra pars compacta and improved motor performance on rotarod and cylinder tests[@troyer2020] |
| Cytoplasmic relocalization | O-GlcNAcylated TDP-43 showed reduced cytoplasmic aggregation in cellular models of TDP-43 pathology |
| Splicing function preservation | O-GlcNAc-modified TDP-43 retained its nuclear splicing function in minigene reporter assays, while unmodified TDP-43 lost function as it mislocalized |
| Stress granule dynamics | O-GlcNAcylation altered TDP-43's incorporation into stress granules, a pre-aggregation state in FTLD/ALS |
| Synapsin I and NMDA receptors | Key presynaptic (Synapsin I) and postsynaptic (NR1, NR2A/B subunits) proteins are O-GlcNAc-modified, and their O-GlcNAcylation correlated with improved cognitive performance in mouse studies |
| Long-term potentiation | OGA inhibition enhanced theta-burst induced LTP in hippocampal brain slices by ~40%, suggesting direct enhancement of synaptic plasticity mechanisms |
| Associated Diseases | Aging, Als, Alzheimer, ALZHEIMER'S DISEASE |
| Known Drugs/Compounds | BERBERINE, BPMC, C-Phycocyanin, CURCUMIN, DIMETHYL FUMARATE, Flavonoids |
| Interactions | 6-OHDA, ABCA1, ABCA7, ABCB1, ABCD1, ABCD2 |
| KG Connections | 6352 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
subgraph Signaling["Signaling"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| MICROGLIA["MICROGLIA"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| CANCER["CANCER"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| NRF2["NRF2"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| Inflammation["Inflammation"]
INFLAMMATION["INFLAMMATION"] -->|"regulates"| Autophagy["Autophagy"]
INFLAMMATION["INFLAMMATION"] -->|"regulates"| Mtor["Mtor"]
IL6["IL6"] -->|"activates"| INFLAMMATION["INFLAMMATION"]
AUTOPHAGY["AUTOPHAGY"] -->|"regulates"| INFLAMMATION["INFLAMMATION"]
P53["P53"] -->|"regulates"| INFLAMMATION["INFLAMMATION"]
CYTOKINES_2["CYTOKINES"] -.->|"inhibits"| INFLAMMATION["INFLAMMATION"]
end
subgraph Pathology["Pathology"]
INFLAMMATION["INFLAMMATION"] -->|"associated with"| AGING["AGING"]
CYTOKINES["CYTOKINES"] -->|"associated with"| INFLAMMATION["INFLAMMATION"]
end
subgraph Therapeutic["Therapeutic"]
INFLAMMATION["INFLAMMATION"] -->|"therapeutic target"| Als["Als"]
INFLAMMATION["INFLAMMATION"] -->|"therapeutic target"| Autoimmune["Autoimmune"]
CYTOKINES_1["CYTOKINES"] -->|"therapeutic target"| INFLAMMATION["INFLAMMATION"]
end
style INFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style MICROGLIA fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CANCER fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NRF2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AGING fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autoimmune fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Mtor fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style IL6 fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style P53 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | inhibits | disease | 1.00 |
| Neuroinflammation | therapeutic_target | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| IL-6 | activates | gene | 1.00 |
| TNF-Α | activates | gene | 1.00 |
| Lipid Metabolism | therapeutic_target | pathway | 1.00 |
| Pyroptosis | activates | pathway | 1.00 |
| NEUROINFLAMMATION | therapeutic_target | gene | 1.00 |
| Tgf-Β | regulates | pathway | 1.00 |
| Cholesterol | regulates | pathway | 1.00 |
| Cholesterol | activates | pathway | 1.00 |
| Ferroptosis | activates | pathway | 1.00 |
| Infection | associated_with | disease | 1.00 |
| Innate Immunity | activates | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Carcinoma | associated_with | disease | 1.00 |
| Inflammasome | regulates | pathway | 1.00 |
| TNF | activates | gene | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Autophagy | inhibits | pathway | 1.00 |
| Inflammasome | inhibits | pathway | 1.00 |
| Angiogenesis | activates | pathway | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Adaptive Immunity | activates | pathway | 1.00 |
| Autoimmune | associated_with | disease | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Stroke | associated_with | disease | 1.00 |
| MTOR | targets | gene | 1.00 |
| Insulin Resistance | associated_with | disease | 1.00 |
| Insulin Resistance | associated_with | disease | 1.00 |
| Oxidative Stress | associated_with | pathway | 1.00 |
| Oxidative Stress | associated_with | pathway | 1.00 |
| Nf-Κb | associated_with | pathway | 1.00 |
| Apoptosis | associated_with | pathway | 1.00 |
| Nf-Κb | associated_with | pathway | 1.00 |
| Neurogenesis | activates | pathway | 1.00 |
| Nf-Κb | inhibits | pathway | 1.00 |
| Apoptosis | associated_with | pathway | 1.00 |
| Blood-Brain Barrier | associated_with | pathway | 1.00 |
| Obesity | associated_with | disease | 1.00 |
| Dementia | associated_with | disease | 1.00 |
| Parkinson | associated_with | disease | 1.00 |
| Depression | associated_with | disease | 1.00 |
| AMYLOID | associated_with | gene | 1.00 |
| Lipid Metabolism | associated_with | pathway | 1.00 |
| CYTOKINES | associated_with | gene | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| NRF2 | activates | gene | 1.00 |
| DEPRESSION | associated_with | gene | 1.00 |
| Phagocytosis | activates | pathway | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CYTOKINES | activates | gene | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| MITOPHAGY | activates | gene | 1.00 |
| PROINFLAMMATORY CYTOKINES | activates | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| JAK2 | inhibits | gene | 1.00 |
| AMPK | inhibits | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| BCL-2 | activates | gene | 1.00 |
| P53 | regulates | gene | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 1.00 |
| PI3K | therapeutic_target | gene | 1.00 |
| ERK | inhibits | gene | 1.00 |
| DNA | therapeutic_target | gene | 1.00 |
| APP | activates | gene | 1.00 |
| APOE | inhibits | gene | 1.00 |
| MMP9 | therapeutic_target | gene | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| MITOCHONDRIA | associated_with | gene | 1.00 |
| TNF | expressed_in | gene | 1.00 |
| Cardiovascular | associated_with | disease | 1.00 |
| Neuroinflammation | associated_with | disease | 1.00 |
| PI3K | activates | gene | 1.00 |
| STROKE | associated_with | gene | 1.00 |
| Carcinoma | associated_with | disease | 1.00 |
| P53 | associated_with | gene | 1.00 |
| BRAIN INJURY | associated_with | gene | 1.00 |
| GENES | expressed_in | gene | 1.00 |
| PTEN | inhibits | gene | 1.00 |
| GFAP | biomarker_for | gene | 1.00 |
| SIRT1 | activates | gene | 1.00 |
| APOPTOSIS | targets | gene | 1.00 |
| SQSTM1 | activates | gene | 1.00 |
| CGAS | activates | gene | 1.00 |
| CYTOKINES | targets | gene | 1.00 |
| Atherosclerosis | associated_with | disease | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 1.00 |
| DEPRESSION | associated_with | gene | 1.00 |
| PHAGOCYTOSIS | associated_with | gene | 1.00 |
| Fibrosis | associated_with | disease | 1.00 |
| ROS | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| IL-6 | associated_with | gene | 1.00 |
| PARKINSON | associated_with | gene | 1.00 |
| Obesity | associated_with | disease | 1.00 |
| PARKINSON'S DISEASE | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| PGC-1α knockout analysis of PV+ interneuron maturation | validation | neurodevelopmental disorders | 0.850 | 0.00 | knockout mice | proposed | N/A |
| PV+ interneuron subtype diversification analysis | exploratory | neurodevelopmental disorders | 0.750 | 0.00 | mouse cortical PV+ interneuron | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Obesity-induced pyroptotic adipocyte death leads to TREM2-dependent macrophage d [PMID:41509917] | Choi C, Lee J, Park G, Namgoong S, Lee Y | iScience | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] | Hegdekar N, Sarkar C, Bustos S, Ritzel R | Autophagy | 2023 | 0 |
| Inflammasome assembly in neurodegenerative diseases. [PMID:37633753] | Singh J, Habean ML, Panicker N | Trends in neurosciences | 2023 | 0 |
| NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938] | Li S, Sun Y, Song M, Song Y, Fang Y, Zha | JCI insight | 2021 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
| Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407] | Gordon R, Albornoz EA, Christie DC, Lang | Science translational medicine | 2018 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning INFLAMMATION in their description or question text
Score: 0.703 · neurodegeneration · 2026-04-16
**Molecular Mechanism and Rationale** The pathogenesis of Parkinson's disease (PD) involves complex interactions betwee
Score: 0.680 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The molecular mechanism underlying AQP4-mediated neuroinflammation centers on the
Score: 0.670 · neurodegeneration · 2026-04-25
This hypothesis reconciles conflicting C1q phenotypes by placing receiver-cell state downstream of a common upstream C1q
Score: 0.665 · translational neuroscience · 2026-04-12
## Mechanistic Overview Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker sta
Score: 0.650 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The molecular foundation of this therapeutic approach centers on the dual functio
Score: 0.643 · neuroinflammation · 2026-04-21
## **Molecular Mechanism and Rationale** The epigenetic silencing of the AIF1 (Allograft Inflammatory Factor 1) gene lo
Score: 0.626 · unknown disease · 2026-04-16
## Mechanistic Overview Peripheral-to-Central Inflammation Circuit Breaker starts from the claim that modulating IL1B wi
Score: 0.610 · neuroscience · 2026-04-22
**Molecular Mechanism and Rationale** The apolipoprotein E4 (APOE4) isoform, present in approximately 25% of the popula
Score: 0.601 · neuroinflammation · 2026-04-15
## Mechanistic Overview STING Antagonism Prevents Acute-to-Chronic Neuroinflammation Transition via Interruption of IFN-
Score: 0.587 · Alzheimer's disease · 2026-04-04
# Cardiovascular-Neuroinflammation Crosstalk Interruption: Targeting Shared Inflammatory Mediators in Neurodegeneratio
Score: 0.580 · neuroinflammation · 2026-04-21
## Mechanistic Overview Astrocyte cGAS/STING Activation Converts Protective into Destructive Neuroinflammation starts fr
Score: 0.580 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The proposed mechanism centers on a complex inflammatory cascade initiated by APO
Score: 0.571 · Neuroinflammation · 2026-04-20
**Molecular Mechanism and Rationale** The PINK1/PARK2 mitophagy pathway represents a critical quality control mechanism
Score: 0.550 · neurodegeneration · 2026-04-25
BET Bromodomain Inhibition for Neuroinflammation Suppression
Score: 0.515 · lipidomics · 2026-04-25
Astrocyte-Specific DGAT1 Inhibition to Prevent Lipid Droplet-Induced Neuroinflammation